[HTML][HTML] Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor

PC Wong, DJP Pinto, D Zhang - Journal of thrombosis and thrombolysis, 2011 - Springer
Abstract Apixaban (BMS-562247; 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)
phenyl)-4, 5, 6, 7-tetrahydro-1 H-pyrazolo [3, 4-c] pyridine-3-carboxamide), a direct inhibitor …

[引用][C] Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor

PC Wong, DJP Pinto, D Zhang - Journal of Thrombosis and …, 2011 - cir.nii.ac.jp
Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学 …

Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor

PC Wong, DJP Pinto, D Zhang - Journal of Thrombosis and Thrombolysis, 2011 - infona.pl
Apixaban (BMS-562247; 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl) phenyl)-4, 5,
6, 7-tetrahydro-1H-pyrazolo [3, 4-c] pyridine-3-carboxamide), a direct inhibitor of activated …

[PDF][PDF] Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor

PC Wong, DJP Pinto, D Zhang - J Thromb Thrombolysis, 2011 - Citeseer
Abstract Apixaban (BMS-562247; 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)
phenyl)-4, 5, 6, 7-tetrahydro-1H-pyrazolo [3, 4-c] pyridine-3-carboxamide), a direct inhibitor …

Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor

PC Wong, DJP Pinto, D Zhang - Journal of thrombosis …, 2011 - pubmed.ncbi.nlm.nih.gov
Apixaban (BMS-562247; 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl) phenyl)-4, 5,
6, 7-tetrahydro-1H-pyrazolo [3, 4-c] pyridine-3-carboxamide), a direct inhibitor of activated …

Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor

PC Wong, J Donald, P Pinto… - Journal of Thrombosis …, 2011 - search.proquest.com
Abstract Apixaban (BMS-562247; 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)
phenyl)-4, 5, 6, 7-tetrahydro-1H-pyrazolo [3, 4-c] pyridine-3-carboxamide), a direct inhibitor …

[HTML][HTML] Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor

PC Wong, DJP Pinto, D Zhang - Journal of Thrombosis and …, 2011 - ncbi.nlm.nih.gov
Abstract Apixaban (BMS-562247; 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)
phenyl)-4, 5, 6, 7-tetrahydro-1H-pyrazolo [3, 4-c] pyridine-3-carboxamide), a direct inhibitor …

Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor.

PC Wong, DJ Pinto, D Zhang - Journal of Thrombosis and …, 2011 - europepmc.org
Abstract Apixaban (BMS-562247; 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)
phenyl)-4, 5, 6, 7-tetrahydro-1H-pyrazolo [3, 4-c] pyridine-3-carboxamide), a direct inhibitor …

Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor.

PC Wong, DJ Pinto, D Zhang - Journal of Thrombosis and …, 2011 - europepmc.org
Abstract Apixaban (BMS-562247; 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)
phenyl)-4, 5, 6, 7-tetrahydro-1H-pyrazolo [3, 4-c] pyridine-3-carboxamide), a direct inhibitor …

[引用][C] Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor

PC WONG, DJP PINTO, D ZHANG - Journal of thrombosis and …, 2011 - Springer